Roles of p38 MAPKs in invasion and metastasis (Q37977166)

26 August 2017

Roles of p38 MAPKs in invasion and metastasis (English)

1 reference

26 August 2017

Ivan del Barco Barrantes

series ordinal

1

1 reference

PubMed ID

22260669

26 August 2017

Angel R Nebreda

series ordinal

2

1 reference

PubMed ID

22260669

26 August 2017

language of work or name

1 reference

1 February 2012

1 reference

Biochemical Society Transactions

26 August 2017

1 reference

26 August 2017

40

1 reference

26 August 2017

1

1 reference

26 August 2017

79-84

1 reference

Metastasis: from dissemination to organ-specific colonization

26 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Models, mechanisms and clinical evidence for cancer dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Mechanisms and functions of p38 MAPK signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

p38 MAP kinase's emerging role as a tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Signal integration by JNK and p38 MAPK pathways in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Noncanonical TGF-β signaling during mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Snail up-regulates proinflammatory mediators and inhibits differentiation in oral keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

p38 maintains E-cadherin expression by modulating TAK1-NF-kappa B during epithelial-to-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

CXCL12 and C5a trigger cell migration via a PAK1/2-p38α MAPK-MAPKAP-K2-HSP27 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

uPAR: a versatile signalling orchestrator

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Integrin β3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Phenotype-assisted transcriptome analysis identifies FOXM1 downstream from Ras-MKK3-p38 to regulate in vitro cellular invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

p38gamma MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

TrkA overexpression enhances growth and metastasis of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Apoptosis commitment and activation of mitochondrial Bax during anoikis is regulated by p38MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

p38α Signaling Induces Anoikis and Lumen Formation During Mammary Morphogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Involvement of p38alpha mitogen-activated protein kinase in lung metastasis of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Activation of p38 has opposing effects on the proliferation and migration of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20110676

21 January 2018

Identifiers

DOI

10.1042/BST20110676

1 reference

26 August 2017

1 reference

PubMed ID

22260669